Gastrointestinal Stromal Tumors Information Center
Gastrointestinal stromal tumors (GISTs) are relatively rare cancers that originate in specialized cells lining the digestive tract. According to the American Cancer Society, between 4,500 and 6,000 people are diagnosed with GIST each year in the United States. In an effort to improve both survival and quality of life among people with GIST, researchers have explored new approaches to targeted therapy, surgery, and supportive care (care to manage cancer symptoms and treatment side effects).
Understanding GIST treatment options, the role of different doctors specializing in the treatment of GIST, and how and when to access new and innovative GIST treatment options available through clinical trials is essential in order to achieve the best outcome from GIST treatment.
The Cancer Consultants GIST Information Center has been designed to help patients understand GIST and GIST treatment options while providing ongoing information, inspiration, support, and community to individuals affected by a diagnosis of GIST.
Headline GIST News 
Clinical Trial Participation Is Inadequate
Some populations are under-represented
Three Years of Treatment with Gleevec Improves Survival in Gastrointestinal Stromal Tumors (GIST
Longer treatment may improve outcomes.
Nexavar Shows Promise against Drug-Resistant GIST
Phase II trial among patients resistant to Gleevec and Sutent
Gastrointestinal Stromal Tumors Tips
Preparing for Surgery You can help ensure that your surgery and recovery go smoothly and that you have...
Know the Signs of Depression in Cancer Patients Because a significant number of cancer patients—an estimated 25 percent—experience...
Cancer Navigators Cancer navigators offer patients guidance as they find their way through a cancer journey.
Gastrointestinal Stromal Tumors Management
Inspiration, Hope & Resources
Jack & Jill Late Stage Cancer Foundation Jon Albert, founder of the Jack & Jill Late Stage Cancer Foundation shows the...
Moving Bodies, Changing Lives Moving On Aerobics helps women regain joy of movement and physical fitness after...
Where Kids Can Be Kids… And Cancer Takes a Back Seat Cancer camps for kids provide fun and camaraderie for children facing down a cancer...
Gastrointestinal Stromal Tumors Conference Coverage
Update in the Management of Gastrointestinal Stromal Tumors (GIST): A Report from ASCO 2007 Update in the Management of Gastrointestinal Stromal Tumors (GIST): A Report from...
Sarcoma Clinical Trials
AP23573-07-302 – Pivotal Trial to Determine the Efficacy and Safety of AP23573 when Administered as Maintenance Therapy to Patients with Metastatic Soft-Tissue or Bone Sarcomas
COGAEWS07B1 – A COG Study for Collecting and Banking Ewing Sarcoma Specimens
ET743-SAR-3002 – A multicenter, open-label single-arm study of YONDELIS (trabectedin) for subjects with locally advanced or metastatic soft tissue sarcoma who have relapsed or are refractory to standard of care treatment.
 |
 |
 |
 |
